Publication | Closed Access

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

VaccinationTumor ImmunologyCancer ImmunosurveillanceMelanomaImmunologyTherapeutic VaccineAutologous Dendritic CellsMalignant MelanomaDermatologyPhase I/ii TrialImmunotherapyMedicine